We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+9.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.1B
AUM Growth
+$2.24B
(+5.5%)
Cap. Flow
-$849M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
2,563
New
364
Increased
1,030
Reduced
917
Closed
227
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$245M |
| 2 |
Meta Platforms (Facebook)
META
|
+$204M |
| 3 |
Exelon
EXC
|
+$196M |
| 4 |
Sherwin-Williams
SHW
|
+$182M |
| 5 |
Pfizer
PFE
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$400M |
| 2 |
Fidelity National Information Services
FIS
|
+$280M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$230M |
| 4 |
ServiceNow
NOW
|
+$222M |
| 5 |
Nike
NKE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.65% |
| 2 | Healthcare | 16.47% |
| 3 | Consumer Discretionary | 15.27% |
| 4 | Industrials | 11.92% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Zimmer Biomet
ZBH
$18B
| $5.31M | 0.01% |
+36,565
| New | +$5.05M |
|
|
ODP
827
DELISTED
ODP
ODP
| $5.28M | 0.01% |
192,595
+26,640
| +16% | +$593K |
|
|
MNTA
828
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.26M | 0.01% |
266,400
+162,600
| +157% | +$2.6M |
|
829
Weyerhaeuser
WY
$17.3B
| $5.23M | 0.01% |
173,280
-26,500
| -13% | -$769K |
|
830
Colliers International
CIGI
$5.22B
| $5.23M | 0.01% |
67,042
+14,863
| +28% | +$1.07M |
|
831
Landstar System
LSTR
$6.54B
| $5.23M | 0.01% |
45,900
+2,900
| +7% | +$327K |
|
832
Bain Capital Specialty
BCSF
$818M
| $5.21M | 0.01% |
+268,914
| New | +$5.06M |
|
833
Ericsson
ERIC
$31.5B
| $5.21M | 0.01% |
594,000
+578,900
| +3,834% | +$5.12M |
|
|
CIT
834
DELISTED
CIT Group Inc.
CIT
| $5.18M | 0.01% |
113,600
+74,000
| +187% | +$3.31M |
|
835
BioCryst Pharmaceuticals
BCRX
$2.49B
| $5.18M | 0.01% |
1,501,812
+626,900
| +72% | +$1.58M |
|
836
FTI Consulting
FCN
$4.92B
| $5.18M | 0.01% |
46,800
+1,800
| +4% | +$197K |
|
837
Allegiant Air
ALGT
$2.68B
| $5.17M | 0.01% |
29,707
-1,600
| -5% | -$265K |
|
|
HEES
838
DELISTED
H&E Equipment Services
HEES
| $5.16M | 0.01% |
154,485
+17,600
| +13% | +$571K |
|
|
DOOR
839
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $5.16M | 0.01% |
71,400
+34,000
| +91% | +$2.24M |
|
840
Arch Capital
ACGL
$36.4B
| $5.15M | 0.01% |
120,031
-167,863
| -58% | -$6.96M |
|
|
OSB
841
DELISTED
Norbord Inc.
OSB
| $5.1M | 0.01% |
190,900
+128,521
| +206% | +$3.43M |
|
|
FSCT
842
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $5.09M | 0.01% |
155,300
-131,500
| -46% | -$4.31M |
|
843
The RMR Group
RMR
$344M
| $5.08M | 0.01% |
111,400
-5,200
| -4% | -$241K |
|
844
Equinix
EQIX
$103B
| $5.08M | 0.01% |
8,700
+7,288
| +516% | +$4.1M |
|
845
Valmont Industries
VMI
$9.51B
| $5.08M | 0.01% |
33,900
+1,500
| +5% | +$212K |
|
846
JELD-WEN Holding
JELD
$98.2M
| $5.07M | 0.01% |
216,500
-5,900
| -3% | -$121K |
|
847
Tetra Tech
TTEK
$8.33B
| $5.07M | 0.01% |
294,000
-111,500
| -27% | -$1.93M |
|
848
Acco Brands
ACCO
$381M
| $5.07M | 0.01% |
541,165
+50,100
| +10% | +$474K |
|
849
Insperity
NSP
$1.93B
| $5.06M | 0.01% |
58,800
+1,420
| +2% | +$124K |
|
850
Expedia Group
EXPE
$33.4B
| $5.05M | 0.01% |
46,719
+10,900
| +30% | +$1.28M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, Two Sigma Advisers held 2,563 positions worth $43.1B, up 5.5% from $40.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers's Q4 2019 filing shows 364 new, 1,030 increased, 917 reduced and 227 closed positions. Its largest new stake was Netflix: 5,465,000 shares worth $177M. The largest sale was Microsoft, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2019 buy was Netflix: 5,465,000 shares worth $177M.
- Two Sigma Advisers added most to Merck in Q4 2019, an estimated $245M increase.
- Two Sigma Advisers's biggest Q4 2019 reduction was Microsoft, cutting an estimated $400M.
- Two Sigma Advisers fully exited Fidelity National Information Services in Q4 2019, selling an estimated $280M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $43.1B portfolio in Q4 2019.
- Two Sigma Advisers opened 364 new positions and closed 227 in Q4 2019.
- Two Sigma Advisers's portfolio value rose 5.5% quarter-over-quarter to $43.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.